Gene: MARVELD1
Official Full Name: MARVEL domain containing 1provided by HGNC
Gene Summary: Predicted to be a structural constituent of myelin sheath. Predicted to be involved in myelination. Predicted to be located in several cellular components, including cytoskeleton; nucleus; and plasma membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04799 | MARVELD1 Knockout cell line (HeLa) | Human | MARVELD1 | 1:3~1:6 | Negative | Online Inquiry |
KO04800 | MARVELD1 Knockout cell line (HCT 116) | Human | MARVELD1 | 1:2~1:4 | Negative | Online Inquiry |
KO04801 | MARVELD1 Knockout cell line (HEK293) | Human | MARVELD1 | 1:3~1:6 | Negative | Online Inquiry |
KO04802 | MARVELD1 Knockout cell line (A549) | Human | MARVELD1 | 1:3~1:4 | Negative | Online Inquiry |
MARVELD1 Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to knock out the MARVELD1 gene, which plays a significant role in processes such as cell adhesion, migration, and the response to various stressors. By utilizing CRISPR-Cas9 technology, these cell lines facilitate the precise deletion of the MARVELD1 gene, allowing for the study of its functions and interactions within cellular environments. The knockout mechanism leads to altered cellular phenotypes, thereby enabling researchers to investigate downstream effects and elucidate pathways influenced by MARVELD1.
The scientific importance of MARVELD1 Gene Knockout Cell Lines lies in their application across various fields, including cancer research, immunology, and developmental biology. Researchers can leverage these cell lines to explore the role of MARVELD1 in tumorigenesis, immune responses, or even cellular differentiation. Furthermore, the knockout cell lines serve as invaluable tools for testing therapeutic interventions, as understanding the MARVELD1 gene's contribution to disease states can uncover novel targets for drug development.
Compared to traditional gene knockout methods, the use of CRISPR-Cas9 technology in producing MARVELD1 knockout cell lines offers distinct advantages, including high efficiency, reduced off-target effects, and a streamlined workflow that accelerates research timelines. Additionally, the specificity of the knockout leads to reproducible results, which is paramount for the rigor of scientific research.
For researchers and clinicians, the value of employing MARVELD1 Gene Knockout Cell Lines is multifaceted; they facilitate comprehensive studies that can inform clinical strategies and drive innovations in therapeutic approaches. By elucidating the functional role of MARVELD1, these cell lines pave the way for enhanced understanding of disease mechanisms and potential interventions.
Our company specializes in the generation of high-quality genetically modified cell lines, and we are committed to advancing the field of biological research through precision tools that empower scientists in their quest for knowledge.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.